Nektar Pharma - possible short squeeze

NASDAQ:NKTR   Nektar Therapeutics
This is a speculative one as counter trend.

Huge volume stepped in around $16 & $20

reuters data on November 28th shows short interest of 18% of the float, and 11 days to cover. The stock hi fresh highs since august and could pressure those short, extending the potential upside

stop below 20 and target 30.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.